Bio-CR Oral Controlled-Release DDS technology is incorporated with captive API of proprietary manufacturing process and/or proprietary crystalline forms, coupled with non-infringing formulation/manufacturing process know-how, thereby allowing development of proprietary solid dosage forms and manufacturing processes within a relatively short development time period. It’s focused on developing low-solubility and super-saturation drug products.
Major Advantages versus Conventional Solid Dosage Products: